用恩西芬治疗慢性阻塞性肺病:系统性审查
Sultan Almuntashiri1, Moaddey Alfarhan2, Aaron Chase3,4
1Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
在中度至重度慢性阻塞性肺病 (COPD) 患者中,恩西芬显著改善了肺功能和呼吸道症状. 这种双重PDE3和4抑制剂表现出良好的安全性,支持其在COPD治疗中的使用.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的慢性阻塞性肺病 (COPD) 维持疗法提供了有限的改善,尽管结合方法.
- 针对不同机制的新型治疗对于减少COPD恶化和改善患者症状至关重要.
研究的目的:
- 评估与安慰剂相比,恩西芬在治疗中度至重度的慢性肺炎方面的综合疗效和安全性.
- 评估恩西芬对肺功能和呼吸系统症状评分的影响.
主要方法:
- 对三项随机对照试验 (RCT) 的系统综述,涉及恩西芬 (每天两次3毫克) 与安慰剂.
- 综合分析了1,715名患者的数据 (1,057名患者接受了恩西芬,658名患者接受了安慰剂).
- 评估主要结果 (FEV1) 和次要结果 (呼吸系统症状得分).
主要成果:
- 与安慰剂相比,恩西芬对峰值,平均值和早晨低谷FEV1显著改善 (p <0.05).
- 呼吸系统症状得分显著改善,包括COPD呼吸系统症状评估 (E-RS:COPD) 工具和过渡性呼吸障碍指数 (TDI) (p < 0.02).
- 恩西芬林和安慰剂组之间的不良事件发生率相似.
结论:
- 恩西芬在中度至重度的COPD患者中持续改善肺功能和症状得分.
- 该药物表现出安全的副作用概况.
- 这一系统性审查支持恩西芬在治疗COPD方面的临床益处.
更多相关视频
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
